Skip to main content
. 2018 Nov 9;9(88):35813–35829. doi: 10.18632/oncotarget.26287

Figure 11.

Figure 11

Fluorescence images (400X magnification) of the GSH/pH-NS (green) in DU-145 (A) and PC-3 (C) cells. Comparison between untreated cells (CTR) and cells treated with 0.1–10 μM GSH/pH-NS after 4 h; (B) Intracellular SL content in DU-145 (B) and PC-3 (D) cells 24 h after treatment with 0.1–10 μM free SLs or SL-loaded GSH/pH-NS.